Bsl-3 Laboratory Protocol
Bsl-3 Laboratory Protocol - Related Videos
11:13
Safety Precautions and Operating Procedures in an (A)BSL-4 Laboratory: 3. Aerobiology
0 Views •
Cited by 9 •
2016
As high-consequence pathogens can potentially infect subjects through airborne particles, aerobiology has been increasingly applied in pathogenesis research and medical countermeasure development. We present a detailed visual demonstration of aerobiology procedures during an aerosol challenge in nonhuman primates in an animal biosafety level 4 maximum containment environment.
09:54
Safety Precautions and Operating Procedures in an (A)BSL-4 Laboratory: 1. Biosafety Level 4 Suit Laboratory Suite Entry and Exit Procedures
0 Views •
Cited by 21 •
2016
Although researchers are generally knowledgeable about procedures and safety precautions required for biosafety level 1 or 2 (BSL-1/2) experiments, they may not be familiar with experimental procedures in BSL-4 suit laboratories. This article provides a detailed visual demonstration of BSL-4 suit laboratory systems check, laboratory entry, movement, and exit procedures.
08:53
Safety Precautions and Operating Procedures in an (A)BSL-4 Laboratory: 2. General Practices
0 Views •
Cited by 7 •
2016
Performing viral assays in a BSL-4 laboratory is more involved compared to work in a BSL-2 laboratory due to required additional safety precautions. Here, we present an overview of practices and procedures used inside a BSL-4 laboratory illustrating proper Class II biosafety cabinet usage, waste management/disposal, and sample removal.
09:36
Safety Precautions and Operating Procedures in an (A)BSL-4 Laboratory: 4. Medical Imaging Procedures
0 Views •
Cited by 8 •
2016
Here, we present an overview of the preparation and animal handling procedures required to safely perform medical imaging in an animal biosafety level 4 laboratory. Computed tomography of a mock-infected guinea pig illustrates these procedures that may be used to evaluate the disease caused by a high consequence pathogen.
07:59
Adapting Gastrointestinal Organoids for Pathogen Infection and Single Cell Sequencing under Biosafety Level 3 (BSL-3) Conditions
0 Views •
Cited by 2 •
2021
This protocol describes how to infect human intestinal organoids from either their apical or basolateral side to characterize host/pathogen interactions at the single-cell level using single-cell RNA sequencing (scRNAseq) technology.
FAQs
Protection comes from combining independent controls rather than relying on one precaution. Restricted access limits who can enter, controlled airflow helps manage movement of potentially contaminated air, protective equipment reduces personnel exposure, and careful culture manipulation limits the creation or spread of hazards. Decontamination then addresses materials and waste, creating a coordinated barrier system for personnel, the community, and experimental integrity.
Culture-handling practices directly influence whether infectious material remains contained during an experiment. Careful manipulation reduces opportunities for exposure and unintended release, while appropriate protective equipment provides an additional barrier for personnel. These measures are especially important when researchers study pathogen replication or host responses, because reliable containment must be maintained throughout active work with cultures, not only during entry or cleanup.
Validated decontamination provides evidence that materials and waste have been treated through an effective containment step. This is different from simply removing items from the work area, because the process must be demonstrated as suitable for limiting hazards before disposal or further handling. It supports both biosafety and trustworthy research by reducing the possibility that infectious material remains associated with laboratory outputs.
Controlled airflow is a facility-level measure that helps manage how air moves around work involving hazardous pathogens. By supporting containment of inhalation-related hazards, it complements personal protective equipment and careful handling practices. The same coordinated environment also helps protect experimental integrity, since unintended movement of contaminants can threaten personnel safety while potentially affecting cultures, observations, or interpretation of infection-related results.
A high-level workflow begins by limiting access to authorized personnel and establishing the required facility controls before work starts. Personnel then use appropriate protective equipment and handle cultures carefully during the experiment. Afterward, materials and waste undergo validated decontamination, while containment practices remain in place until the work area is addressed. This sequence links preparation, active handling, and closure.
Planning should address both the laboratory environment and the actions performed within it. Relevant controls include restricted access, controlled airflow, appropriate protective equipment, careful procedures for manipulating cultures, and validated treatment of materials and waste. Considering these elements together helps match the containment approach to hazards associated with serious disease and inhalation, rather than treating safety as an isolated equipment choice.
It is relevant when studies involve hazardous pathogens and require work on pathogen replication, host immune responses, transmission-related hazards, or experimental countermeasures. The protocol provides the containment framework that allows these questions to be investigated while reducing exposure and release risks. It therefore connects biosafety practice with research goals, helping preserve personnel protection, community safety, and the integrity of infection-related findings.